An underground economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on new investigations.
Investigational Treatment Acquiring Traction Via Social Media
Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Followers are encouraged to message these accounts privately for source information, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the drug there before directing customers to other platforms for transactions.
Understanding Retatrutide
Retatrutide is an experimental injectable created by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Professionals Voice Worries
However, physicians and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could lead to users administering products of uncertain source.
Several experts said the demand for the experimental drug could be linked to the rising cost of approved weight loss treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for human use under the British medical regulations.
Several content creators try to sidestep the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, advertising, and customer laws, risking fines, prosecution or prison.
Platform Reaction and Content Elimination
According to TikTok, the platform has taken down problematic material and banned related keywords and query recommendations. The organization stated it was committed to keeping the platform secure and investing in strengthening enforcement strategies.
Digital Trading Operations
Research also discovered communities with up to nine thousand participants marketing the experimental drug using the platform's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly displays channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at residence.
Within minutes of entering one group, a vendor shared contact information, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within two days. When asked whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. Not one inquired about weight, medical conditions or previous experience.
Item Details and Costs
Inside these groups, messages show dark colored packages with postal service labels, claiming to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use injectors usually priced at 160 pounds for 20mg. When questioned how much time a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Warnings
“Individuals are injecting materials they can’t verify. Even if the research behind retatrutide is valid, these online products may not contain what they claim,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service connected the surge in demand to current cost increases for approved weight-loss drugs such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were produced in was clean,” she explained.
Her staff has previously encountered patients harmed by personal administration from unconfirmed sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said the doctor. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A representative from the pharmaceutical company stated the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can sell [it] for personal consumption,” they said, adding that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially serious medical dangers”.
